Hu et al11 demonstrated that there were 64 (1.03%) carriers of BRCA1 and BRCA2 pathogenic germline variants in 6220 Chinese non‐small cell lung cancer (NSCLC) patients, with BRCA2 variants being the most predominant. Here, BRCA2 is linked to non-small cell lung carcinoma.